Because Vγ9Vδ2 T cells recognize these mevalonate metabolites in tumor cells, the high amounts of IPP and ApppI in zoledronate-treated tumor cells contributes to their recognition and lysis 35. This evidence concerns the gene IPP and neoplasm.